RINVOQ (Upadacitinib) 15mg/30mg Tablets | China-Sourced | JAK1 Inhibitor | GLT

Generic Information: RINVOQ (Upadacitinib) — China-Sourced

RINVOQ is AbbVie's brand name for upadacitinib, a once-daily oral Janus kinase (JAK) inhibitor designed to target JAK1 specifically. It is one of the broadest JAK inhibitors on the market, cleared for conditions ranging from rheumatoid arthritis to atopic dermatitis and several bowel and spine diseases. In China RINVOQ is NMPA-approved and listed on the national reimbursement catalogue (乙类), which pulls its real-world cost well below Western list prices — so the China-sourced RINVOQ that GLT supplies is the same AbbVie originator at a more accessible price.

What Is RINVOQ (Upadacitinib) Used For?

RINVOQ treats a wide set of immune-mediated inflammatory diseases. Its indications include:

• Rheumatoid arthritis — moderate to severe active disease in adults with an inadequate response to TNF inhibitors.
• Psoriatic arthritis — active disease in adults with an inadequate response to DMARDs.
• Atopic dermatitis — moderate to severe eczema in adults and adolescents aged 12 and older.
• Ulcerative colitis and Crohn's disease — moderate to severe active disease in adults.
• Ankylosing spondylitis and non-radiographic axial spondyloarthritis.

How Does RINVOQ (Upadacitinib) Work?

Upadacitinib blocks a single enzyme, JAK1, that sits inside immune cells and relays signals from inflammatory cytokines. Because JAK1 is the shared relay for many of the cytokines behind these diseases, shutting it down reduces inflammation across the joints, skin, gut and spine. Its selectivity for JAK1 over other JAK family members is part of what gives RINVOQ its once-daily dosing and its particular safety profile.

Indications

• Moderate to severe active rheumatoid arthritis in adults
• Active psoriatic arthritis in adults
• Moderate to severe atopic dermatitis in adults and adolescents 12+ years
• Moderate to severe active ulcerative colitis and Crohn's disease in adults
• Active ankylosing spondylitis and non-radiographic axial spondyloarthritis

Dosage & Administration

RINVOQ is taken as one tablet once daily, with or without food. For rheumatoid arthritis, psoriatic arthritis and spondyloarthritis the dose is 15 mg daily. Atopic dermatitis starts at 15 mg daily, rising to 30 mg for more severe disease. Ulcerative colitis and Crohn's disease use a 45 mg daily induction dose, then 15 mg or 30 mg daily for maintenance. The China-sourced pack contains 28 tablets in either 15 mg or 30 mg strength. Swallow whole — do not split, crush or chew.

Side Effects

The most common reactions are upper respiratory tract infections, nausea, cough and fever. The serious risks are serious infections, shingles, blood clots, major cardiovascular events and certain cancers including lymphoma. RINVOQ carries a boxed warning covering these, and a tuberculosis test is recommended before starting. Discuss your full medical history with your doctor.

Storage & Handling

Keep RINVOQ tablets in the original pack at room temperature, shielded from moisture and light, and out of children's reach. Do not use past the expiry date.

Why Choose RINVOQ (Upadacitinib) from China?

• NMPA-approved and nationally reimbursed — a fully registered AbbVie originator from China's regulated chain.
• Meaningful cost saving — China's reimbursement pricing typically undercuts US/EU list prices sharply.
• Selective JAK1 inhibitor, once daily — broad coverage of immune conditions in a single daily tablet.
• GLT sourcing — GIVE LIFE TIME LIMITED ships batch-traceable China-sourced RINVOQ with documentation.

How to Order RINVOQ (Upadacitinib) from GLT?

1. Contact GLT via WhatsApp +86 15234153837 or email [email protected] with the strength and quantity you need.
2. Receive a formal quotation, payment instructions and delivery estimate.
3. Complete payment through our secure channel (Hao Yi Lian / 好易联).
4. Your order is dispatched with batch documentation and tracking to delivery.

GLT serves licensed institutions and individual patients; a valid prescription may be requested before dispatch.

FAQ

1. Is China-sourced RINVOQ (upadacitinib) genuine?

Yes. It is the authentic AbbVie product, NMPA-approved and supplied from China's regulated pharmaceutical chain, with batch documentation.

2. What is the price of RINVOQ (upadacitinib) in China?

China's reimbursed pricing is typically well below US/EU list prices. Contact GLT for an exact quotation for your quantity and destination.

3. What conditions does RINVOQ treat?

RINVOQ treats rheumatoid arthritis, psoriatic arthritis, atopic dermatitis, ulcerative colitis, Crohn's disease, ankylosing spondylitis and non-radiographic axial spondyloarthritis.

4. Where can I buy upadacitinib?

You can buy RINVOQ and generic upadacitinib through GLT via WhatsApp +86 15234153837 or email [email protected].

5. Does upadacitinib require a prescription?

Yes, upadacitinib is a prescription medicine, and a valid prescription may be requested before dispatch.